14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $5.34 $19.02 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Mar 27, 2019 $5.52 $5.54 $5.30 $5.48 74 119
Mar 26, 2019 $5.50 $5.63 $5.00 $5.52 66 461
Mar 25, 2019 $5.60 $5.60 $5.25 $5.51 153 230
Mar 22, 2019 $5.90 $5.90 $5.52 $5.59 54 769
Mar 21, 2019 $5.81 $6.00 $5.75 $5.92 76 925
Mar 20, 2019 $5.68 $5.95 $5.62 $5.85 118 509
Mar 19, 2019 $5.62 $5.79 $5.52 $5.70 228 214
Mar 18, 2019 $5.78 $5.82 $5.54 $5.70 182 585
Mar 15, 2019 $5.54 $5.68 $5.42 $5.68 168 060
Mar 14, 2019 $5.52 $5.55 $5.46 $5.54 211 212
Mar 13, 2019 $5.51 $5.59 $5.45 $5.54 263 523
Mar 12, 2019 $5.55 $5.58 $5.46 $5.50 106 112
Mar 11, 2019 $5.60 $5.60 $5.41 $5.51 116 065
Mar 08, 2019 $5.44 $5.56 $5.41 $5.51 122 299
Mar 07, 2019 $5.57 $5.63 $5.30 $5.52 154 400
Mar 06, 2019 $5.40 $5.67 $5.40 $5.61 481 072
Mar 05, 2019 $6.82 $6.87 $5.40 $5.45 346 439
Mar 04, 2019 $6.18 $6.83 $6.07 $6.83 47 091
Mar 01, 2019 $7.15 $7.25 $6.01 $6.18 172 951
Feb 28, 2019 $7.24 $7.45 $6.96 $7.16 242 308
Feb 27, 2019 $6.72 $7.65 $6.30 $7.22 206 877
Feb 26, 2019 $6.25 $6.75 $6.19 $6.69 213 784
Feb 25, 2019 $5.38 $6.16 $5.36 $6.06 219 358
Feb 22, 2019 $5.25 $5.38 $5.13 $5.31 29 664
Feb 21, 2019 $5.13 $5.31 $5.13 $5.22 34 232
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT